Related Experiment Video
Updated: Feb 5, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
MiRNA Dysregulation in Childhood Hematological Cancer
Jaqueline Carvalho de Oliveira1, Gabriela Molinari Roberto2, Mirella Baroni3
1Department Genetics, Federal University of Paraná, 80060-000 Paraná, Brazil. jaqbiomed@yahoo.com.br.
Abstract:
For decades, cancer biology focused largely on the protein-encoding genes that have clear roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome instability, drug resistance, or signaling pathways that stimulate growth, angiogenesis, or metastasis. MicroRNAs (miRNAs), however, represent one of the more abundant classes of cell modulators in multicellular organisms and largely contribute to regulating gene expression. Many of the ~2500 miRNAs discovered to date in humans regulate vital biological processes, and their aberrant expression results in pathological and malignant outcomes. In this review, we highlight what has been learned about the roles of miRNAs in some of the most common human pediatric leukemias and lymphomas, along with their value as diagnostic/prognostic factors.
Insights
MicroRNAs (miRNAs) are key gene regulators implicated in pediatric leukemias and lymphomas. This review explores their roles and diagnostic potential in these childhood cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Traditional cancer biology research focused on protein-encoding genes.
- MicroRNAs (miRNAs) are crucial regulators of gene expression in multicellular organisms.
- Aberrant miRNA expression is linked to various pathological and malignant outcomes.
Purpose of the Study:
- To review the roles of miRNAs in common pediatric leukemias and lymphomas.
- To highlight the diagnostic and prognostic value of miRNAs in these cancers.
Main Methods:
- Literature review of studies on miRNAs in pediatric leukemia and lymphoma.
- Analysis of miRNA expression patterns and their correlation with disease characteristics.
Main Results:
- MicroRNAs play significant roles in the development and progression of pediatric leukemias and lymphomas.
- Specific miRNAs are associated with different subtypes and clinical outcomes.
- MiRNAs show potential as biomarkers for diagnosis and prognosis.
Conclusions:
- MicroRNAs are critical players in pediatric hematological malignancies.
- Further research into miRNAs can lead to improved diagnostic and prognostic tools for childhood leukemia and lymphoma.
Related Concept Videos
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
MicroRNAs
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

